IBL HealthCare Limited (PSX:IBLHL)

Pakistan · Delayed Price · Currency is PKR

41.07

-0.30 (-0.73%)

At close: Oct 19, 2026

Market Cap	4.05B -20.9%
Revenue (ttm)	4.61B +6.6%
Net Income	220.40M +5.8%
EPS	2.24 +5.8%
Shares Out	98.53M
PE Ratio	18.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,791
Open	41.06
Previous Close	41.37
Day's Range	41.00 - 41.70
52-Week Range	36.00 - 85.82
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About IBL HealthCare

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddler, baby cereals, infant formulas, medical and lifestyle nutrition, and specialty nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as sealer hollow fiber hemodialyzer, tubing sets for hemodialysis, hemodialysis double lumen catheter kits, and disposable AV fistula needles; critical care and an... [Read more]

Industry Food & Drug Retailing

Sector Consumer Non-Cyclicals

Founded 1997

Employees 208

Stock Exchange Pakistan Stock Exchange

Ticker Symbol IBLHL

Full Company Profile

Financial Performance

In fiscal year 2026, IBL HealthCare's revenue was 4.61 billion, an increase of 6.59% compared to the previous year's 4.32 billion. Earnings were 220.40 million, an increase of 5.77%.

Financial Statements